CJK-IPR UPDATE
TRADEMARKS The Delhi High court in a case [1] temporarily restrained Novakind Bio sciences Private Limited from using its pharmaceutical products bearing the word “KIND” on the ground that it could cause confusion among the public into believing that its pharmaceutical products have something to do with the mark “Mankind”. Mankind argued that the suffix “KIND” is a dominant feature